The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation

about

The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation

Item

http://www.wikidata.org/entity/Q57106119

description

article

@en

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

The Terry Fox Research Institu ...... ohort for biomarker validation

@en

The Terry Fox Research Institu ...... ohort for biomarker validation

@nl

type

Item

label

The Terry Fox Research Institu ...... ohort for biomarker validation

@en

The Terry Fox Research Institu ...... ohort for biomarker validation

@nl

prefLabel

The Terry Fox Research Institu ...... ohort for biomarker validation

@en

The Terry Fox Research Institu ...... ohort for biomarker validation

@nl

P1476

The Terry Fox Research Institu ...... ohort for biomarker validation

@en

P2093

Alain Bergeron

http://www.w3.org/2001/XMLSchema#string

Anne-Marie Mes-Masson

http://www.w3.org/2001/XMLSchema#string

Armen Aprikian

http://www.w3.org/2001/XMLSchema#string

Darrel Drachenberg

http://www.w3.org/2001/XMLSchema#string

Dominique Trudel

http://www.w3.org/2001/XMLSchema#string

Fadi Brimo

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Lattouf

http://www.w3.org/2001/XMLSchema#string

Jeremy A Squire

http://www.w3.org/2001/XMLSchema#string

Ladan Fazli

http://www.w3.org/2001/XMLSchema#string

Laurence Klotz

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer -what has gone wrong? A blueprint for the way forward in biomarker studies

Beyond PSA: the next generation of prostate cancer biomarkers.

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Diagnostic and prognostic molecular biomarkers for prostate cancer.

A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.

Disruption of prostate epithelial differentiation pathways and prostate cancer development.

Spatial genomic heterogeneity within localized, multifocal prostate cancer.

Novel biomarkers for prostate cancer: An evidence-based review for use in clinical practice.

A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.

A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores.

P2888

s12894-018-0392-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12894-018-0392-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert G. Bristow

Véronique Ouellet

Fred Saad

P577

2018-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106905911

http://www.w3.org/2001/XMLSchema#string

P698

30200929

http://www.w3.org/2001/XMLSchema#string

P921

urology

reproductive medicine

biomarker

P932

6131811

http://www.w3.org/2001/XMLSchema#string